Multiple Organ Dysfunction Syndrome in Children With Sepsis: Role of Genetic Factors

Castellanos-Ortega, 2002, A new prognostic scoring system for meningococcal septic shock in children. Comparison with three other scoring systems, Intensive Care Med, 28, 341, 10.1007/s00134-001-1196-z Bagshaw, 2006, Fluid resuscitation and the septic kidney, Curr Opin Crit Care, 12, 527, 10.1097/01.ccx.0000247446.09500.ac Licari, 2007, Fluid resuscitation and the septic kidney: the evidence, Contrib Nephrol, 156, 167, 10.1159/000102080 Nussbaum, 2001, Genetic variation in individuals: mutation and polymorphism, 79 van Deventer, 2000, Cytokine and cytokine receptor polymorphisms in infectious disease, Intensive Care Med, 26, S98, 10.1007/s001340051125 1992, American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, Crit Care Med, 20, 864, 10.1097/00003246-199206000-00025 Jaber, 1996, Inflammatory mediators in sepsis: rationale for extracorporeal therapies, Am J Kidney Dis, 28, S35, 10.1016/S0272-6386(96)90078-5 Pinsky, 1993, Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality, Chest, 103, 565, 10.1378/chest.103.2.565 Casey, 1993, Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome, Ann Intern Med, 119, 771, 10.7326/0003-4819-119-8-199310150-00001 Scumpia, 2005, Biology of interleukin-10 and its regulatory roles in sepsis syndromes, Crit Care Med, 33, S468, 10.1097/01.CCM.0000186268.53799.67 Song, 2005, Interleukin-6, Crit Care Med, 33, S463, 10.1097/01.CCM.0000186784.62662.A1 Dinarello, 2005, Interleukin-1beta, Crit Care Med, 33, S460, 10.1097/01.CCM.0000185500.11080.91 Koch, 1998, Origin and mediators involved in sepsis and the systemic inflammatory response syndrome, Kidney Int, 53, S66 Opal, 2000, Anti-inflammatory cytokines, Chest, 117, 1162, 10.1378/chest.117.4.1162 Tabardel, 1996, Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men, Surgery, 119, 76, 10.1016/S0039-6060(96)80217-0 Fillinger, 2002, Glucocorticoid effects on the inflammatory and clinical responses to cardiac surgery, J Cardiothorac Vasc Anesth, 16, 163, 10.1053/jcan.2002.31057 Wilson, 1993, An allelic polymorphism within the human tumor necrosis factor-alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles, J Exp Med, 177, 557, 10.1084/jem.177.2.557 Morse, 1999, Induced heteroduplex genotyping of TNF-alpha, IL-1beta, IL-6 and IL-10 polymorphisms associated with transcriptional regulation, Cytokine, 11, 789, 10.1006/cyto.1999.0491 Abraham, 1999, Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease, J Leukoc Biol, 66, 562, 10.1002/jlb.66.4.562 Wilson, 1997, Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation, Proc Natl Acad Sci U S A, 94, 3195, 10.1073/pnas.94.7.3195 Kroeger, 1997, The -308 tumor necrosis factor-α promoter polymorphism effects transcription, Mol Immunol, 34, 391, 10.1016/S0161-5890(97)00052-7 Warzocha, 1998, Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome, Blood, 91, 3574, 10.1182/blood.V91.10.3574 Louis, 1998, Tumor necrosis factor gene polymorphism influences TNF-alpha production in lipopolysaccharide-stimulated whole blood cell culture in healthy humans, Clin Exp Immunol, 113, 401, 10.1046/j.1365-2249.1998.00662.x Mira, 1999, Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study, JAMA, 282, 561, 10.1001/jama.282.6.561 Tang, 2000, Tumor necrosis factor gene polymorphism and septic shock in surgical infection, Crit Care Med, 28, 2733, 10.1097/00003246-200008000-00008 Weitkamp, 2000, Pilot study assessing TNF gene polymorphism as a prognostic marker for disease progression in neonates with sepsis, Infection, 28, 92, 10.1007/s150100050053 Wunderink, 2002, Tumor necrosis factor gene polymorphisms and the variable presentation and outcome of community-acquired pneumonia, Chest, 121, 87S, 10.1378/chest.121.3_suppl.87S Nadel, 1996, Variation in the tumor necrosis factor-α promoter region may be associated with death from meningococcal disease, J Infect Dis, 174, 878, 10.1093/infdis/174.4.878 Mcguire, 1994, Variation of the TNF-α promoter region associated with susceptibility to cerebral malaria, Nature, 371, 508, 10.1038/371508a0 Cabrera, 1995, Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis, J Exp Med, 182, 1259, 10.1084/jem.182.5.1259 Jaber, 2004, Cytokine promoter gene polymorphisms and mortality in acute renal failure, Cytokine, 25, 212, 10.1016/j.cyto.2003.11.004 Treszl, 2002, Interleukin genetic variants and the risk of renal failure in infants with infection, Pediatr Nephrol, 17, 713, 10.1007/s00467-002-0935-x Bokodi, 2005, The association of the carrier state of the tumor necrosis factor-alpha (TNFalpha) -308A allele with the duration of oxygen supplementation in preterm neonates, Eur Cytokine Netw, 16, 78 Abraham, 1991, Haplotypic polymorphisms of the TNFB gene, Immunogenetics, 33, 50, 10.1007/BF00211695 Pociot, 1991, A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus, Scand J Immunol, 33, 37, 10.1111/j.1365-3083.1991.tb02490.x Stuber, 1996, A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis, Crit Care Med, 24, 381, 10.1097/00003246-199603000-00004 Majetschak, 1999, Relation of a TNF gene polymorphism to severe sepsis in trauma patients, Ann Surg, 230, 207, 10.1097/00000658-199908000-00011 Heesen, 2003, Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: association with TNF-alpha response of granulocytes to endotoxin stimulation, Crit Care Med, 31, 211, 10.1097/00003246-200301000-00032 Read, 2003, Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease, Ann Intern Med, 138, 534, 10.7326/0003-4819-138-7-200304010-00009 Virta, 2002, Increased frequency of interleukin-1beta (-511) allele 2 in febrile seizures, Pediatr Neurol, 26, 192, 10.1016/S0887-8994(01)00380-0 Berger, 2002, C-reactive protein levels are influenced by common IL-1 gene variations, Cytokine, 17, 171, 10.1006/cyto.2001.0974 Santtila, 1998, Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1β production in vitro, Scand J Immunol, 47, 195, 10.1046/j.1365-3083.1998.00300.x Andus, 1997, Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2, Gut, 41, 651, 10.1136/gut.41.5.651 Tountas, 1999, Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis, Gastroenterology, 117, 806, 10.1016/S0016-5085(99)70338-0 Fang, 1999, Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis, Crit Care Med, 27, 1330, 10.1097/00003246-199907000-00024 Ma, 2002, Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients, Crit Care Med, 30, 1046, 10.1097/00003246-200205000-00015 Barton, 1997, IL-6: insights into novel biological activities, Clin Immunol Immunopathol, 85, 16, 10.1006/clin.1997.4420 Fishman, 1998, The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis, J Clin Invest, 102, 1369, 10.1172/JCI2629 Fernandez-Real, 2000, Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects, J Clin Endocrinol Metab, 85, 1331, 10.1210/jc.85.3.1334 Schluter, 2002, Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis, Crit Care Med, 30, 32, 10.1097/00003246-200201000-00005 Baier, 2006, IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants, BMC Med, 4, 10, 10.1186/1741-7015-4-10 Crawley, 1999, Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis, Arthritis Rheum, 42, 1101, 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y van der Pol, 2001, Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease, J Infect Dis, 184, 1548, 10.1086/324662 Gallagher, 2003, Association of IL-10 polymorphism with severity of illness in community acquired pneumonia, Thorax, 58, 154, 10.1136/thorax.58.2.154 Jaber, 2004, Polymorphism of immuno-modulatory cytokine genes: implications in acute renal failure, Blood Purif, 22, 101, 10.1159/000074930 Yanamandra, 2005, Interleukin-10 -1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants, Pediatr Pulmonol, 39, 426, 10.1002/ppul.20182 Hoebee, 2004, Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis, J Infect Dis, 189, 239, 10.1086/380908 Segerer, 2003, Chemokines and chemokine receptors in renal pathology, Curr Opin Nephrol Hypertens, 12, 243, 10.1097/00041552-200305000-00004 Segerer, 2005, Chemokines in renal diseases, Sci World J, 5, 835, 10.1100/tsw.2005.105 Miura, 2001, Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury, Am J Pathol, 159, 2137, 10.1016/S0002-9440(10)63065-9 Maier, 2000, Massive chemokine transcription in acute renal failure due to polymicrobial sepsis, Shock, 14, 187, 10.1097/00024382-200014020-00019 Jiang, 2003, Genetic susceptibility to enteroaggregative Escherichia coli diarrhea polymorphism in the IL-8 promotor region at position -251, J Infect Dis, 188, 506, 10.1086/377102 Hull, 2000, Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families, Thorax, 55, 1023, 10.1136/thorax.55.12.1023 Kruger, 2002, A monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation, J Am Soc Nephrol, 13, 2585, 10.1097/01.ASN.0000031701.53792.54 Amoli, 2002, Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis, J Rheumatol, 29, 2367 Amanatidou, 2008, RANTES promoter gene polymorphisms and susceptibility to severe respiratory syncytial virus-induced bronchiolitis, Pediatr Infect Dis J, 27, 38, 10.1097/INF.0b013e31814d4e42 Macdonald, 2003, Oxidative stress and gene expression in sepsis, Br J Anaesth, 90, 221, 10.1093/bja/aeg034 Hoy, 2002, Growing significance of myeloperoxidase in non-infectious diseases, Clin Chem Lab Med, 40, 2, 10.1515/CCLM.2002.002 Ursini, 1995, Diversity of glutathione peroxidases, Methods Enzymol, 252, 38, 10.1016/0076-6879(95)52007-4 Flohe, 1988, Glutathione peroxidase, Basic Life Sci, 49, 663 Sies, 1999, Glutathione and its role in cellular functions, Free Radic Biol Med, 27, 916, 10.1016/S0891-5849(99)00177-X Forsberg, 2001, Oxidative stress, human genetic variation, and disease, Arch Biochem Biophys, 389, 84, 10.1006/abbi.2001.2295 Fukai, 2002, Extracellular superoxide dismutase and cardiovascular disease, Cardiovasc Res, 55, 239, 10.1016/S0008-6363(02)00328-0 Baliga, 1999, Oxidant mechanisms in toxic acute renal failure, Drug Metab Rev, 31, 971, 10.1081/DMR-100101947 Druml, 1998, Fat-soluble vitamins in patients with acute renal failure, Miner Electrolyte Metab, 24, 220, 10.1159/000057374 Metnitz, 2000, Impact of acute renal failure on antioxidant status in multiple organ failure, Acta Anaesthesiol Scand, 44, 236, 10.1034/j.1399-6576.2000.440304.x Balakrishnan, 2003, Antioxidant and oxidative stress indices in dialysis-dependent acute renal failure, Blood Purif, 21, 213, 10.1159/000070692 Inoue, 1998, Polymorphism of the NADH/NADPH oxidase p22phox gene in patients with coronary artery disease, Circulation, 97, 135, 10.1161/01.CIR.97.2.135 Guzik, 2000, Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis, Circulation, 102, 1744, 10.1161/01.CIR.102.15.1744 Hodgkinson, 2003, Association of the p22phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes, Diabetes Care, 26, 3111, 10.2337/diacare.26.11.3111 Forsberg, 2001, A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels, Free Radic Biol Med, 30, 500, 10.1016/S0891-5849(00)00487-1 Nadif, 2005, Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli, Free Radic Res, 39, 1345, 10.1080/10715760500306711 Perianayagam, 2007, NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure, J Am Soc Nephrol, 18, 255, 10.1681/ASN.2006070806 Platonov, 1998, Association of human Fc gamma RIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease, Clin Infect Dis, 27, 746, 10.1086/514935 Domingo, 2002, Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease, Am J Med, 112, 19, 10.1016/S0002-9343(01)01047-6 Domingo, 2004, Relevance of genetically determined host factors to the prognosis of meningococcal disease, Eur J Clin Microbiol Infect Dis, 23, 634, 10.1007/s10096-004-1167-8 Smith, 2003, FcgammaRIIa and FcgammaRIIIb polymorphisms were not associated with meningococcal disease in Western Norway, Epidemiol Infect, 130, 193, 10.1017/S0950268802008087 Bathum, 2006, Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis, Mol Immunol, 43, 473, 10.1016/j.molimm.2005.02.017 Haralambous, 2006, Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients, Scand J Infect Dis, 38, 764, 10.1080/00365540600643203 Hermans, 1999, 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group, Lancet, 354, 556, 10.1016/S0140-6736(99)02220-5 Westendorp, 1999, Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock, Lancet, 354, 561, 10.1016/S0140-6736(98)09376-3 Geishofer, 2005, 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia, Eur J Pediatr, 164, 486, 10.1007/s00431-005-1673-4 Haralambous, 2003, Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children, Crit Care Med, 31, 2788, 10.1097/01.CCM.0000100122.57249.5D Binder, 2007, 4G4G genotype of the plasminogen activator inhibitor-1 promoter polymorphism associates with disseminated intravascular coagulation in children with systemic meningococcemia, J Thromb Haemost, 5, 2049, 10.1111/j.1538-7836.2007.02724.x Kremer Hovinga, 2004, A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease, J Thromb Haemost, 2, 54, 10.1111/j.1538-7836.2004.00557.x Read, 2000, An interleukin-1 genotype is associated with fatal outcome of meningococcal disease, J Infect Dis, 182, 1557, 10.1086/315889 Endler, 2006, Polymorphisms in the interleukin-1 gene cluster in children and young adults with systemic meningococcemia, Clin Chem, 52, 511, 10.1373/clinchem.2005.058537 Harding, 2002, Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism, Am J Respir Crit Care Med, 165, 1103, 10.1164/ajrccm.165.8.2108089 Balding, 2003, Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease?, Genes Immun, 4, 533, 10.1038/sj.gene.6364020 Ridker, 1999, Assessment of genetic markers for coronary thrombosis: promise and precaution, Lancet, 353, 687, 10.1016/S0140-6736(99)00067-7 Newman, 1988, Enhancing causal inference in observational studies, 98 Nabel, 2003, Genomic medicine: cardiovascular disease, N Engl J Med, 349, 60, 10.1056/NEJMra035098 Ioannidis, 2005, Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials, J Clin Epidemiol, 58, 543, 10.1016/j.jclinepi.2004.10.019 Rosenthal, 1998, In search of perverse polymorphisms, N Engl J Med, 338, 122, 10.1056/NEJM199801083380210 Star, 1998, Treatment of acute renal failure, Kidney Int, 54, 1817, 10.1046/j.1523-1755.1998.00210.x Molitoris, 2003, Transitioning to therapy in ischemic acute renal failure, J Am Soc Nephrol, 14, 265, 10.1097/01.ASN.0000048852.53881.D9 Jaber, 2004, Polymorphism of immunomodulatory cytokine genes: implications in acute renal failure, Blood Purif, 22, 101, 10.1159/000074930 Aidoo, 2001, Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX, Genet Epidemiol, 21, 201, 10.1002/gepi.1029